Yurima Hernández de la Rosa

Anglicisms in Spanish: Apropos of “Into the Heart of Terminology”

preferred indication criteria for the polypill in the context of secondary prevention of CV disease, although the new evidence on polypill use and the introduction of the new 40 mg atorvastatin dosage form do broaden the therapeutic spectrum of patients who could benefit from its use. Furthermore, these developments justify the update to the consensus document on the clinical use of the polypill as CV risk prevention, which will allow clinical staff more uniformity in making decisions in line with the available evidence.